BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10713330)

  • 1. STAT6 and the regulation of CD23 expression in B-chronic lymphocytic leukemia.
    Kneitz C; Goller M; Seggewiss R; Yaman A; Serfling E; Tony HP
    Leuk Res; 2000 Apr; 24(4):331-7. PubMed ID: 10713330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT6, NF-kappaB and C/EBP in CD23 expression and IgE production.
    Tinnell SB; Jacobs-Helber SM; Sterneck E; Sawyer ST; Conrad DH
    Int Immunol; 1998 Oct; 10(10):1529-38. PubMed ID: 9796920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The two CD23 isoforms display differential regulation in chronic lymphocytic leukaemia.
    Fournier S; Yang LP; Delespesse G; Rubio M; Biron G; Sarfati M
    Br J Haematol; 1995 Feb; 89(2):373-9. PubMed ID: 7873388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD23 antigen regulation and signaling in chronic lymphocytic leukemia.
    Fournier S; Delespesse G; Rubio M; Biron G; Sarfati M
    J Clin Invest; 1992 Apr; 89(4):1312-21. PubMed ID: 1532590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathways controlling the expression of surface CD21 (CR2) and CD23 (Fc(epsilon)IIR) proteins in human malignant B cells.
    Shubinsky G; Schlesinger M; Polliack A; Rabinowitz R
    Leuk Lymphoma; 1997 May; 25(5-6):521-30. PubMed ID: 9250823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CD23 antigen and its regulation by IL-4 in chronic lymphocytic leukemia.
    Sarfati M; Fournier S; Christoffersen M; Biron G
    Leuk Res; 1990; 14(1):47-55. PubMed ID: 2137545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of interleukin-10 receptor expression on B-cell chronic lymphocytic leukemia cells.
    Jurlander J; Lai CF; Tan J; Chou CC; Geisler CH; Schriber J; Blumenson LE; Narula SK; Baumann H; Caligiuri MA
    Blood; 1997 Jun; 89(11):4146-52. PubMed ID: 9166857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CD23b promoter is a target for NF-AT transcription factors in B-CLL cells.
    Kneitz C; Goller M; Tony H; Simon A; Stibbe C; König T; Serfling E; Avots A
    Biochim Biophys Acta; 2002 Oct; 1588(1):41-7. PubMed ID: 12379312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGF-1 potentiation of IL-4-induced CD23/Fc(epsilon)RII expression in human B cells.
    Kim JH; Park HH; Lee CE
    Mol Cells; 2003 Jun; 15(3):307-12. PubMed ID: 12872985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of signal transducer and activation of transcription (STAT)6 and STAT3 expression in stimulated B and T cells.
    Arinobu Y; Sugimoto R; Akaiwa M; Arima K; Otsuka T; Hamasaki N; Izuhara K
    Biochem Biophys Res Commun; 2000 Oct; 277(2):317-24. PubMed ID: 11032724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of IL-9 induced by STAT6 activation promotes the pathogenesis of chronic lymphocytic leukemia.
    Chen N; Lu K; Li P; Lv X; Wang X
    Int J Clin Exp Pathol; 2014; 7(5):2319-23. PubMed ID: 24966942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Counter-regulation mechanism of IL-4 and IFN-α signal transduction through cytosolic retention of the pY-STAT6:pY-STAT2:p48 complex.
    Kim SH; Lee CE
    Eur J Immunol; 2011 Feb; 41(2):461-72. PubMed ID: 21268015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD23 is recognized as tumor-associated antigen (TAA) in B-CLL by CD8+ autologous T lymphocytes.
    Bund D; Mayr C; Kofler DM; Hallek M; Wendtner CM
    Exp Hematol; 2007 Jun; 35(6):920-30. PubMed ID: 17533046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells.
    Fluckiger AC; Brière F; Zurawski G; Bridon JM; Banchereau J
    Immunology; 1994 Nov; 83(3):397-403. PubMed ID: 7530690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-4-induced STAT6 suppresses IFN-gamma-stimulated STAT1-dependent transcription in mouse macrophages.
    Ohmori Y; Hamilton TA
    J Immunol; 1997 Dec; 159(11):5474-82. PubMed ID: 9548487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repression of IL-4-induced gene expression by IFN-gamma requires Stat1 activation.
    Venkataraman C; Leung S; Salvekar A; Mano H; Schindler U
    J Immunol; 1999 Apr; 162(7):4053-61. PubMed ID: 10201928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo activation of signal transducer and activator of transcription 1 after CD154 gene therapy for chronic lymphocytic leukemia is associated with clinical and immunologic response.
    Battle TE; Wierda WG; Rassenti LZ; Zahrieh D; Neuberg D; Kipps TJ; Frank DA
    Clin Cancer Res; 2003 Jun; 9(6):2166-72. PubMed ID: 12796382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine modulation of nuclear factor-kappaB activity in B-chronic lymphocytic leukemia.
    Zaninoni A; Imperiali FG; Pasquini C; Zanella A; Barcellini W
    Exp Hematol; 2003 Mar; 31(3):185-90. PubMed ID: 12644014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma irradiation up-regulates expression of B cell differentiation molecule CD23 by NF-kappaB activation.
    Rho HS; Park SS; Lee CE
    J Biochem Mol Biol; 2004 Jul; 37(4):507-14. PubMed ID: 15469741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NOTCH2 links protein kinase C delta to the expression of CD23 in chronic lymphocytic leukaemia (CLL) cells.
    Hubmann R; Düchler M; Schnabl S; Hilgarth M; Demirtas D; Mitteregger D; Hölbl A; Vanura K; Le T; Look T; Schwarzmeier JD; Valent P; Jäger U; Shehata M
    Br J Haematol; 2010 Mar; 148(6):868-78. PubMed ID: 19995395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.